SCHEMBL17150702

SCHEMBL17150702

C=CC(=O)N1CCN(C(N)=O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
FGFR4 P22455 1/20 0.41
TET3 O43151 4/20 0.41
KMT2A Q03164 4/20 0.41
FBXL19 Q6PCT2 4/20 0.41
CXXC5 Q7LFL8 4/20 0.41
KDM2B Q8NHM5 4/20 0.41
CXXC4 Q9H2H0 4/20 0.41
KDM2A Q9Y2K7 4/20 0.41
TET1 Q8NFU7 3/20 0.41
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
HTR7 P34969 1/20 0.35
HTR6 P50406 1/20 0.35
MAPK1 P28482 1/20 0.35
TEAD3 Q99594 2/20 0.35
TEAD1 P28347 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL3714624 0.87 ALDH1A1 (0.58) ALDH1A1TSHRFGFR4TET3KMT2A
Acrylamide SCHEMBL8498177 0.87 ALDH1A1 (0.58) ALDH1A1TSHRFGFR4TET3KMT2A
SCHEMBL237862 0.87
SCHEMBL20547259 0.87 TET3 (0.47) ALDH1A1TSHRFGFR4TET3KMT2A
SCHEMBL167151 0.87 TET3 (0.47) ALDH1A1TSHRFGFR4TET3KMT2A
SCHEMBL12764449 0.87 TET3 (0.47) ALDH1A1TSHRFGFR4TET3KMT2A
SCHEMBL422638 0.81
SCHEMBL572569 0.81 ALDH1A1 (0.45) ALDH1A1TSHRKMT2AHTTNPSR1
SCHEMBL20334621 0.80 TET3 (0.41) ALDH1A1TSHRFGFR4TET3KMT2A
SCHEMBL25787464 0.80 TET3 (0.41) ALDH1A1TSHRFGFR4TET3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3100723-B1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC (US) 2019-06-12 EP disclosed
EP-3489232-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2019-05-29 EP disclosed
WO-2015154039-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2015-10-08 WO disclosed